Related Experiment Video
Updated: Apr 14, 2026
A Macrophage-Tumor Spheroid Co-Invasion Assay
Published on: January 24, 2025
Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer
A N Gordon-Weeks1, S Y Lim1, A E Yuzhalin1
1CRUK/MRC Gray Institute for Radiation Oncology & Biology, University of Oxford, UK.
Abstract:
Macrophage migration inhibitory factor (MIF) was one of the first cytokines to be discovered, over 40 years ago. Since that time a burgeoning interest has developed in the role that MIF plays in both the regulation of normal physiology and the response to pathology. MIF is a pleotropic cytokine that functions to promote inflammation, drive cellular proliferation, inhibit apoptosis and regulate the migration and activation state of immune cells. These functions are particularly relevant for the development of cancer and it is notable that various solid tumours over express MIF. This includes tumours of the gastrointestinal tract and MIF appears to play a particularly prominent role in the development and progression of colonic adenocarcinoma. Here we review the role that MIF plays in colonic carcinogenesis through the promotion of colonic inflammation, as well as the progression of primary and metastatic colon cancer. The recent development of various antagonists and antibodies that inhibit MIF activity indicates that we may soon be able to classify MIF as a therapeutic target in colon cancer patients.
Insights
Macrophage migration inhibitory factor (MIF) drives colon cancer development and progression by promoting inflammation and cell growth. Inhibiting MIF may offer a new therapeutic strategy for colon cancer patients.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine discovered over 40 years ago.
- MIF regulates inflammation, cellular proliferation, apoptosis, and immune cell activity.
- MIF is frequently overexpressed in various solid tumors, including gastrointestinal cancers.
Purpose of the Study:
- To review the role of MIF in colonic carcinogenesis.
- To explore MIF's involvement in colon cancer development, progression, and metastasis.
- To discuss MIF as a potential therapeutic target for colon cancer.
Main Methods:
- Literature review of studies on MIF and colon cancer.
- Analysis of MIF's functions in inflammation and cell cycle regulation.
- Examination of MIF's role in primary and metastatic colon cancer.
Main Results:
- MIF promotes colonic inflammation, a key factor in colon cancer initiation.
- MIF drives the proliferation of colon cancer cells and inhibits apoptosis.
- MIF contributes to the progression of primary and metastatic colon cancer.
Conclusions:
- MIF plays a significant role in colon cancer development and progression.
- Inhibitors and antibodies targeting MIF are emerging as potential therapeutics.
- MIF represents a promising therapeutic target for colon cancer treatment.
